Future Market Insights delivers key insights on the North America Vision Care Market in a new publication titled “Vision Care Market: North America Industry Analysis and Opportunity Assessment, 2016 – 2026”. Vision care is a billion dollar market accounting for a substantial proportion of worldwide healthcare expenditure. In terms of revenue, the North America vision care market is expected to reach US$ 39.7 Bn in 2016, witnessing a year-on-year growth of 7.2%. In this report, Future Market Insights analyses the factors and trends impacting the growth and performance of the North America vision care market.

According to Future Market Insights analysts, factors such as rising prevalence of eye diseases leading to eye surgery procedures, an increasing geriatric population, and the introduction of new and advanced vision care products are major factors expected to fuel the revenue growth of the North America vision care market over the forecast period. Economic factors such as growing healthcare expenditure, increasing disposable income per capita, rising government support in developed economies, and favourable reimbursement policies are also expected to boost the growth of the North America vision care market over the forecast period. However, rise in the costs of eye surgery and treatment and a risk of infection and vision loss may hinder the growth of the North America vision care market over the forecast period.

Acquire a stunning sample report featuring compelling graphs and charts. Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-na-2018

Sales of vision care services has remained quite healthy in the U.S. market in the recent years, making North America the most lucrative market globally. The North America vision care market revenue was accounted to be US$ 37.1 Bn in 2015, with the U.S. accounting for majority of revenue share.

Segmentation highlights

The North America vision care market can be broadly classified into six product segments – Rx lenses, frames, non Rx sunglasses, contact lenses, readers, and contact lens solutions – each with different applications.

  • By product, Rx lenses accounted for higher revenue share in North America as compared to other product segments
  • The Frames product type segment accounted for the second largest revenue share followed by the contact lenses product segment in 2015. The contact lenses segment is expected to register the highest CAGR of 12.4% during the forecast period
  • By distribution channel, the retail segment accounted for a higher revenue share in the North America vision care market as compared to other distribution channels
  • The Retail segment is expected to reach a market valuation of US$ 60.6 Bn by 2026, reflecting a CAGR of 9.8% over the forecast period
  • The E-commerce segment is also expanding at a higher rate in the overall North America vision care market. This segment is expected to reach US$ 18.9 Bn by the end of 2026, registering a CAGR of 3.8% over the forecast period

Vendor insights

Key players in the North America vision care market include Johnson & Johnson Vision Care Inc., Valeant Pharmaceuticals International Inc., Novartis AG, The Cooper Companies Inc., SynergEyes Inc., Luxottica, Essilor International, and ZEISS International. Major market players are adopting different strategies such as partnerships and acquisitions to maintain and expand their market share. Recently in January 2016, Valeant pharmaceuticals expanded its specialty lens business with the addition of Alden Optical Laboratories Inc. In 2016, Essilor International reinforced its expansion with independent eye care professionals in the U.S with the acquisition of Vision Source.

Key SegmentBy Product Type

  • Rx-Lenses
  • Frames
  • Contact Lenses
  • Non Rx Sunglasses
  • Reading Glasses
  • Contact Lens Solutions

By Distribution Channel

  • Retail Stores
  • E-Commerce
  • Clinics
  • Hospitals

By Country

  • U.S.
  • Canada

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033